Related Experiment Video
Updated: Jul 1, 2025
09:02
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.5K
Blood-Nanoparticle Interactions Create a Brain Delivery Superhighway for Doxorubicin
Zhuoxuan Li1, Tatyana Kovshova2, Julia Malinovskaya2
1National University of Singapore, Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, Singapore.
International Journal of Nanomedicine
|March 13, 2024
Summary
Polybutyl cyanoacrylate (PBCA) nanoparticles utilize a novel cell hitchhiking mechanism for enhanced brain delivery. This method significantly increases doxorubicin permeation across the blood-brain barrier compared to traditional methods.
Area of Science:
- Nanotechnology
- Neuroscience
- Pharmacology
Background:
- The blood-brain barrier (BBB) is a major challenge for treating brain cancers, limiting drug delivery.
- Doxorubicin is a chemotherapy drug with limited efficacy in brain tumors due to the BBB.
Purpose of the Study:
- To investigate the brain targeting mechanism of doxorubicin-loaded polybutyl cyanoacrylate (PBCA) nanoparticles.
- To understand the interaction of PBCA nanoparticles with the blood-brain barrier (BBB).
Main Methods:
- Utilized an advanced computer model to analyze brain delivery of Doxil® and surfactant-coated PBCA nanoparticles.
- Integrated computational learning with in vitro release and cell interaction studies.
Main Results:
- PBCA nanoparticles demonstrated a unique 'cell hitchhiking' mechanism for brain delivery.
- PBCA nanoparticles showed over a 1000-fold increase in brain permeation rate compared to Doxil®.
- Nonspecific binding to blood cells enhanced PBCA nanoparticle interaction with vascular endothelium, promoting transcytosis.
Conclusions:
- PBCA nanoparticles achieve superior brain uptake through enhanced transcytosis and increased circulation time.
- The cell hitchhiking mechanism offers a promising strategy for improving doxorubicin delivery to brain tumors.
